Hospital
ST. Joseph Hospital & Health Center, INC.
ST. Joseph Hospital & Health Center, INC. was paid $17.89M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoST. JOSEPH HOSPITAL & HEALTH CENTER, INC.
KOKOMO, IN 46901
KOKOMO, IN 46901
33aNPI1780625442assigned 06/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.89M
24GClaims322,627
24DCodes billed100
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#22 of 69
Median peer was paid$9.76M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,050 | $613K | |
| 2019 | 30,929 | $1.01M | |
| 2020 | 51,367 | $2.17M | |
| 2021 | 57,818 | $3.55M | |
| 2022 | 62,459 | $4.12M | |
| 2023 | 53,196 | $4.02M | |
| 2024incomplete | 32,808 | $2.41M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 25,510 | 21,507 | $3.80M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 20,744 | 15,650 | $2.54M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 10% | 3,854 | 1,032 | $1.88M |
| 71045 | Radiologic examination, chest; single view | 6.8% | 9,718 | 7,505 | $1.23M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.8% | 10,453 | 8,047 | $1.04M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 5.1% | 7,955 | 6,376 | $917K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.7% | 2,245 | 1,652 | $846K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.3% | 11,970 | 9,197 | $777K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.9% | 8,458 | 6,121 | $516K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.6% | 7,471 | 4,200 | $471K |
| A0425 | Ground mileage, per statute mile | 2.6% | 21,514 | 14,969 | $458K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 2.4% | 5,318 | 4,091 | $428K |
88 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 2,262 | $363K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 4,234 | $271K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.1% | 1,893 | $193K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 1.0% | 3,666 | $187K |
| 80053 | Comprehensive metabolic panel | 1.0% | 31,751 | $183K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,535 | $164K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 37,021 | $159K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,648 | $155K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,049 | $135K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,905 | $132K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,046 | $115K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 689 | $87K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,713 | $87K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 372 | $78K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,301 | $73K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 809 | $69K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,939 | $52K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,444 | $50K |
| 84484 | <1% | 5,956 | $46K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,411 | $45K |
| 87634 | <1% | 602 | $33K | |
| 81025 | <1% | 5,211 | $31K | |
| 83735 | <1% | 7,420 | $26K | |
| 99223 | Prolong inpt eval add15 m | <1% | 250 | $25K |
| 81001 | <1% | 13,385 | $24K | |
| 83690 | <1% | 6,671 | $23K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,193 | $18K |
| 80306 | <1% | 1,622 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,381 | $14K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 698 | $13K |
| 87088 | <1% | 2,513 | $11K | |
| 80061 | Lipid panel | <1% | 1,018 | $10K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 48 | $9K |
| 83605 | <1% | 1,252 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 710 | $8K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 346 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 353 | $7K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 174 | $6K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 453 | $6K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 221 | $6K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 67 | $5K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 87 | $5K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 144 | $5K |
| 99221 | <1% | 88 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 920 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 31 | $4K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 53 | $4K |
| 86140 | <1% | 778 | $3K | |
| 80081 | <1% | 34 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 276 | $2K |
| 81003 | <1% | 1,411 | $2K | |
| 87040 | <1% | 130 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 16 | $1K |
| 73630 | <1% | 42 | $1K | |
| 80055 | <1% | 32 | $1K | |
| 83880 | <1% | 65 | $1K | |
| 87807 | <1% | 84 | $900.88 | |
| 82105 | <1% | 63 | $892.64 | |
| 82950 | <1% | 220 | $778.91 | |
| 85379 | <1% | 112 | $775.70 | |
| 84145 | <1% | 35 | $724.10 | |
| 85730 | <1% | 297 | $713.79 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 33 | $539.01 |
| 85610 | <1% | 320 | $518.46 | |
| 87077 | <1% | 177 | $504.72 | |
| 84702 | <1% | 40 | $410.76 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 42 | $310.75 |
| 84439 | <1% | 50 | $298.65 | |
| 80179 | <1% | 22 | $260.97 | |
| 80143 | <1% | 22 | $260.97 | |
| 86803 | <1% | 18 | $179.80 | |
| 87081 | <1% | 32 | $163.77 | |
| 80305 | <1% | 109 | $157.07 | |
| 87430 | <1% | 17 | $142.47 | |
| 83540 | <1% | 26 | $139.75 | |
| 83550 | <1% | 14 | $96.14 | |
| 80076 | <1% | 22 | $94.29 | |
| 82607 | <1% | 16 | $93.93 | |
| 84703 | <1% | 14 | $90.24 | |
| 87186 | <1% | 14 | $55.92 | |
| 87075 | <1% | 120 | $4.48 | |
| 87070 | <1% | 120 | $4.26 | |
| 87205 | <1% | 120 | $2.02 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 749 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 36 | $0.00 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 106 | $0.00 |
| A9270 | Non-covered item or service | 0% | 13 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, KATHY (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| ST. Vincent Randolph Hospital, INC. | Winchester, IN | $4.06M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.